Literature DB >> 15315825

Genomic organisation of the human MDM2 oncogene and relationship to its alternatively spliced mRNAs.

Huiling Liang1, Helen Atkins, Rana Abdel-Fattah, Stephen N Jones, John Lunec.   

Abstract

The MDM2 proto-oncogene, which encodes a protein that binds to the p53 tumour suppressor, has been found amplified and overexpressed in a range of human tumours. Although the human MDM2 cDNA sequence has been reported, the genomic organisation of the human gene has not been documented. We have previously reported the detection of five alternative internally deleted MDM2 transcripts in human tumours and suggested these may represent alternatively spliced forms. Here we demonstrate two novel MDM2 transcripts with internal deletions, using RT-PCR followed by sequencing. To definitively ascribe these variant transcript forms to alternative splicing, and to explore associated mechanisms, we have determined the intron--exon organisation of the human genomic sequence. The human MDM2 gene spans approximately 33 kb and is divided into 12 exons. Exon sizes range from 50 to > or =1161 bp and intron sizes vary from 121 to approximately 7000 bp. The positions of intron--exon boundaries are compared with the deletion junctions of the multiple-sized transcripts and discussed in relation to alternative splicing mechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315825     DOI: 10.1016/j.gene.2004.05.015

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Cotranscriptional exon skipping in the genotoxic stress response.

Authors:  Martin Dutertre; Gabriel Sanchez; Marie-Cécile De Cian; Jérôme Barbier; Etienne Dardenne; Lise Gratadou; Gwendal Dujardin; Catherine Le Jossic-Corcos; Laurent Corcos; Didier Auboeuf
Journal:  Nat Struct Mol Biol       Date:  2010-10-24       Impact factor: 15.369

Review 2.  [Value of biomarkers in urology].

Authors:  P J Goebell; B Keck; S Wach; B Wullich
Journal:  Urologe A       Date:  2010-04       Impact factor: 0.639

3.  ROS and p53 in regulation of UVB-induced HDM2 alternative splicing.

Authors:  Lingying Tong; Shiyong Wu
Journal:  Photochem Photobiol       Date:  2014-07-26       Impact factor: 3.421

4.  Splicing up mdm2 for cancer proteome diversity.

Authors:  Danielle R Okoro; Melissa Rosso; Jill Bargonetti
Journal:  Genes Cancer       Date:  2012-03

Review 5.  Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Int J Cancer       Date:  2016-02-08       Impact factor: 7.396

6.  The role of tumor protein 53 mutations in common human cancers and targeting the murine double minute 2-p53 interaction for cancer therapy.

Authors:  Tayebeh Hamzehloie; Majid Mojarrad; Mohammad Hasanzadeh Nazarabadi; Sahar Shekouhi
Journal:  Iran J Med Sci       Date:  2012-03

7.  Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.

Authors:  Danielle R Okoro; Nicoleta Arva; Chong Gao; Alla Polotskaia; Cindy Puente; Melissa Rosso; Jill Bargonetti
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.